Literature DB >> 15291466

Hypolipidemic effects of modified psyllium preparations.

Kenneth G D Allen1, Sandee J Bristow, Liangli Yu.   

Abstract

The hypolipidemic effects of two solid-state enzymatically modified psyllium preparations were compared to that of the original psyllium husks in hamsters. Hamsters were ad libitum fed 0.2 wt % cholesterol diets formulated to contain 12% cellulose or 5% cellulose plus 7% raw or enzymatically modified psyllium preparations. Psyllium additions to the diet did not significantly alter food consumption or the weekly mean hamster weight over the 5 weeks of feeding. However, the total weight gained over 35 days of feeding of modified psyllium Y-26-4, one of the modified psyllium preparations, was significantly lower, 48, 47, and 32% than that for the cellulose, raw psyllium, and modified psyllium Y-24-3 groups, respectively. At 35 days, psyllium feeding significantly reduced plasma total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol by 50-100% in comparison to cellulose feeding, with no significant differences between the psyllium preparations. Fecal dry weight was unaffected by dietary treatment. At days 29-31, fecal bile acid excretion was significantly increased by 30-70% with all three psyllium diets, with no significant differences between psyllium preparations. These results suggest that improving the functional properties of psyllium by solid-state enzymatic procedures, such that its incorporation into food products is feasible, does not alter psyllium-mediated hypolipidemic effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15291466     DOI: 10.1021/jf0497206

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  1 in total

1.  Identification of liver CYP51 as a gene responsive to circulating cholesterol in a hamster model.

Authors:  Haiqiu Huang; Zhuohong Xie; Wallace Yokoyama; Liangli Yu; Thomas T Y Wang
Journal:  J Nutr Sci       Date:  2016-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.